Health
Results from Phase 0/1 trial of ribociclib plus everolimus in patients with high-grade glioma announced – News-Medical.Net
The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer…
The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer in the world, announced results from their Phase 0/1 clinical trial of ribociclib plus everolimus in patients with high-grade…
Continue Reading
-
Business16 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News13 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
Business17 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business13 hours ago1 ASX dividend stock down 43% I’d buy right now